Vai ai contenuti. | Spostati sulla navigazione | Spostati sulla ricerca | Vai al menu | Contatti | Accessibilità

| Crea un account

Bin, Anna (2008) Metabolismo dell'adenosina: correlazione tra processi biochimici e contrattilità nella muscolatura liscia intestinale in condizioni normali e patologiche. [Tesi di dottorato]

Full text disponibile come:

Documento PDF

Abstract (inglese)

In the gastrointestinal tract continued or repeated exposure to pathogens and non-pathogenic antigens may induce activation of epithelial immune system, potentially through dysregulation of barrier functions (Rijnierse et al., 2007). It is well recognized that an inflammatory response, which is largely restricted to the intestinal mucosa, may cause profound changes in the function of smooth muscle and enteric nerves. Some of these changes also occur at remote non-inflamed sites, producing extensive disturbances in gut physiology (Collins et al., 2001).
In the intestine, cyclic AMP has been shown to play a key role in the control of smooth muscle tension. This compound can be extruded from cells upon activation of adenylate ciclase leading to adenosine accumulation via the extracellular cyclic AMP-adenosine pathway (Giron et al., 2008).
In my PhD research work, I first evaluated the mechanical effects of cyclic AMP on rat isolated ileum. Exogenous cyclic AMP concentration-dependently increased intestinal smooth muscle tension. Pretreatment of the preparations with specific inhibitors of ecto- and endo-phosphodiesterases and ecto-5'nucleotidase demonstrated that extracellular cyclic AMP may act on smooth muscle both directly and indirectly through its degradation products. In particular, it was shown that extracellular cyclic AMP-induced ileum contraction was partially inhibited by adenosine inactivation using adenosine deaminase (ADA) or receptor blockade using 8-phenyltheophilline. Moreover, forskolin, that causes endogenous cyclic AMP accumulation, induced concentration-dependent ileum relaxation, supporting distinct roles for the extracellular cyclic AMP-adenosine pathway as opposed to intracellular-generated cyclic AMP. Accordingly, experiments with [3H]-cyclic AMP revealed that [3H]-cyclic AMP uptake in ileum strips was negligible. These findings corroborate the view that cyclic AMP is not only a second messenger but also a source of adenosine.
In vivo treatment of the animals with reserpine affects both contractile effects and metabolic fate of cyclic AMP in the intestine, indicating that the sympathetic system is involved in the modulation of the extracellular cyclic AMP-adenosine pathway.
Considering the significant role of adenosine in regulating intestinal motility, my attention was then focused on CD73 and ecto-ADA, enzymes which directly control extracellular adenosine metabolism. By monitoring the fate of AMP and the generation of adenosine and inosine in the incubation medium of ileum strips, the presence of highly active CD73 and ADA enzymes was demonstrated and the sympathetic system seems to play an important role in regulating these enzymes. The constitutive but regionally distinctive distribution of CD73, ADA and P1 receptors in the intestinal tissue was confirmed by immunoflurescence experiments performed on frozen ileum sections.
In order to understand the functional role of the CD73 and ADA in the smooth muscle, a method for setting up primary cultures of longitudinal intestinal smooth muscle cells (ISMCs) from rat ileum was developed by using the explant technique. Enzyme activity on ISMC surface was investigated by incubation of these cells with exogenous AMP and HPLC detection of nucleotide metabolites. By using specific inhibitors (alpha,beta-methyleneadenosine 5'-diphosphate, concanavalin A, levamisole) CD73 was confirmed to be the only enzyme able to degrade AMP on ISMC surface. On the other hand, high CD73 activity was not followed by activation of ecto-ADA, based on the experiments evaluating the fate of [3H]-cyclic AMP in the culture medium of ISMCs. These experiments also demonstrated that the extracellular cyclic AMP-adenosine pathway is also present in ISMCs. Immunocytochemical analyses confirmed high CD73 expression on the ISMC surface and revealed that ADA and adenosine receptors are primarily localized in the cytosol.
Finally, I evaluated whether the expression of CD73, ADA and P1 receptors in the rat ileum could be affected by an in vivo latent infection in the enteric nervous system induced by Herpes Simplex Virus type 1 (HSV-1). It has been shown that HSV-1 alters intestinal motility and transit, and is currently under evaluation as a potential animal model of gut motility disorders. Immunofluorescence analysis indicated that alterations in the expression of CD73, ADA and P1 receptors were induced not only by HSV-1 latency in the intestine, but also by the progress of infection. In vivo treatment with HSV-1 appears to be responsible for adenosinergic system modifications and intestinal dysmotility, even if histological examination showed no tissue damage.
In conclusion, this PhD thesis highlights the paramount role of CD73, ADA and adenosine receptors in the control of intestinal motility under physiopathological conditions. Furthermore, these proteins should be regarded as potential novel prognostic markers and/or pharmacological targets in neuromuscular abnormalities of the gastrointestinal tract.

Statistiche Download - Aggiungi a RefWorks
Tipo di EPrint:Tesi di dottorato
Relatore:Gaion, Rosa Maria
Correlatore:Giron, Maria Cecilia
Dottorato (corsi e scuole):Ciclo 20 > Corsi per il 20simo ciclo > FARMACOLOGIA E TOSSICOLOGIA, TERAPIA RIANIMATIVA E INTENSIVA
Data di deposito della tesi:Gennaio 2008
Anno di Pubblicazione:Gennaio 2008
Parole chiave (italiano / inglese):adenosina, AMP ciclico, via extracellulare AMP ciclico-adenosina, muscolatura liscia intestinale, CD73/ecto-5'nucleotidasi, adenosina deaminasi, recettori dell'adenosina, ileo di ratto
Settori scientifico-disciplinari MIUR:Area 05 - Scienze biologiche > BIO/14 Farmacologia
Struttura di riferimento:Dipartimenti > Dipartimento di Farmacologia ed Anestesiologia "E. Meneghetti"
Codice ID:422
Depositato il:10 Nov 2008
Simple Metadata
Full Metadata
EndNote Format


I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

1. Adams LD, Lemire JM and Schwartz SM (1999) A systematic analysis of 40 random genes in cultured vascular smooth muscle subtypes reveals a heterogeneity of gene expression and identifies the tight junction gene Zonula Occludens 2 as a marker of epithelioid "pup" smooth muscle cells and a participant in carotid neointimal formation. Arterioscler Thromb Vasc Biol 19:2600-2608. Cerca con Google

2. Adanin S, Yalovetskiy IV, Nardulli BA, Sam AD, Jonjev ZS and Law WR (2002) Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis. Am J Physiol Regul Integr Comp Physiol 282:R1324-1332. Cerca con Google

3. Airas L, Niemelä J, Yegutkin G and Jalkanen S (2007) Mechanism of action of IFN-beta in the treatment of multiple sclerosis: a special reference to CD73 and adenosine. Ann N Y Acad Sci 1110:641-648. Cerca con Google

4. Akkari R, Burbiel J, Hockemeyer J and Müller C (2006) Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs. Curr Top Med Chem 6:1375-1399. Cerca con Google

5. Antonioli L, Fornai M, Colucci R, Ghisu N, Da Settimo F, Natale G, Kastsiuchenka O, Duranti E, Virdis A, Vassalle C, La Motta C, Mugnaini L, Breschi MC, Blandizzi C and Del Tacca M (2007a) Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. J Pharmacol Exp Ther 322:435-442. Cerca con Google

6. Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, Del Tacca M and Blandizzi C (2007b) Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases. Inflammatory Bowel Diseases doi:10.1002/ibd.20316. Cerca con Google

7. Balda MS and Matter K (1998) Tight junctions. J Cell Sci 111:541-547. Cerca con Google

8. Bankir L, Ahloulay M, Devreotes PN and Parent CA (2002) Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved? Am J Physiol Renal Physiol 282:F376-392. Cerca con Google

9. Baumgart DC and Carding SR (2007) Inflammatory bowel disease: cause and immunobiology. The Lancet 369:1627-1640. Cerca con Google

10. Bin A, Giron MC, Calligaro G, Castagliuolo I and Gaion RM (2007) Adenosine receptors and metabolism in the intestinal tract. Book of Abstract Cagliari, June 6-9. Cerca con Google

11. Bin A, Giron MC, Etteri S, Bongiovanni F, Florio C and Gaion RM (2006) Ecto-5’nucleotidase (CD73) activity and expression in the rat ileum. Purinergic Signalling 2:181-182. Cerca con Google

12. Blue WT, Winland RD, Stobbs DG, Kirksey DF and Savage RE (1981) Effects of adenosine monophosphate on the reactivation of latent herpes simplex virus type 1 infections of mice. Antimicrob Agents Chemother 20:547-548. Cerca con Google

13. Bours MJL, Swennen ELR, Di Virgilio F, Cronstein BN and Dagnelie PC (2006) Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacology & Therapeutics 112:358-404. Cerca con Google

14. Cabarrocas J, Savidge TC and Roland SL (2003) Role of enteric glial cells in inflammatory bowel disease. Glia 41:81-93. Cerca con Google

15. Calhau C, Martel F, Hipolito-Reis C and Azevedo I (2000) Differences between duodenal and jejunal rat alkaline phosphatase. Clinical Biochemistry 33:571-577. Cerca con Google

16. Cao L, Martin A, Polakos N and Moynihan JA (2004) Stress causes a further decrease in immunity to herpes simplex virus-1 in immunocompromised hosts. Journal of Neuroimmunology 156:21-30. Cerca con Google

17. Carneiro-Ramos MS, Silva VBd, Júnior MBC, Battastini AMO, Sarkis JJF and Barreto-Chaves MLM (2004) Thyroid hormone stimulates 5’-ecto-nucleotidase of neonatal rat ventricular myocytes. Molecular and Cellular Biochemistry 265:195-201. Cerca con Google

18. Castagliuolo I, Brun P, Costantini M, Rizzetto C, Palu G, Costantino M, Baldan N and Zaninotto G (2004) Esophageal achalasia: is the herpes simplex virus really innocent? Journal of Gastrointestinal Surgery 8:24-30. Cerca con Google

19. Cavalcante IC, Castro MV, Barreto ARF, Sullivan GW, Vale M, Almeida PRC, Linden J, Rieger JM, Cunha FQ, Guerrant RL, Ribeiro RA and Brito GAC (2006) Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis. Infect Immun 74:2606-2612. Cerca con Google

20. CCFA (2007). About Crohn's Disease. Crohn's and Colitis Foundation of America, New York. Cerca con Google

21. Childs KF, Ning XH and Bolling SF (1996) Simultaneous detection of nucleotides, nucleosides and oxidative metabolites in myocardial biopsies. J Chromatogr B Biomed Appl 678:181-186. Cerca con Google

22. Christofi FL (2001) Unlocking mysteries of gut sensory transmission: is adenosine the key? News Physiol Sci 16:201-207. Cerca con Google

23. Christofi FL, Zhang H, Yu JG, Guzman J, Xue J, Kim M, Wang YZ and Cooke HJ (2001) Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system. J Comp Neurol 439:46-64. Cerca con Google

24. Colgan S, Eltzschig H, Eckle T and Thompson L (2006) Physiological roles for ecto-5’-nucleotidase (CD73). Purinergic Signalling 2:351-360. Cerca con Google

25. Collins S, Blennerhassett P, Blennerhassett M and Vermillion D (1989) Impaired acetylcholine release from the myenteric plexus of Trichinella-infected rats. Am J Physiol 257:G898-903. Cerca con Google

26. Collins SM, Piche T and Rampal P (2001) The putative role of inflammation in the irritable bowel syndrome. Gut 49:743-745. Cerca con Google

27. Cordero OJ, Salgado FJ, Fernandez-Alonso CM, Herrera C, Lluis C, Franco R and Nogueira M (2001) Cytokines regulate membrane adenosine deaminase on human activated lymphocytes. J Leukoc Biol 70:920-930. Cerca con Google

28. Correia-de-Sa P, Adaes S, Timoteo MA, Vieira C, Magalhaes-Cardoso T, Nascimento C and Duarte-Araujo M (2006) Fine-tuning modulation of myenteric motoneurons by endogenous adenosine: on the role of secreted adenosine deaminase. Autonomic Neuroscience 126-127:211-224. Cerca con Google

29. Coupar I and Hancock D (1994) The adenosine agonist NECA inhibits intestinal secretion and peristalsis. J Pharm Pharmacol 46:801-804. Cerca con Google

30. Coupar IM (1999) Characterization and tissue location of the neural adenosine receptor in the rat ileum. Br J Pharmacol 126:1269-1275. Cerca con Google

31. Cronstein BN (1994) Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13. Cerca con Google

32. Cronstein BN, Eberle MA, Gruber HE and Levin RI (1991) Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proceedings of the National Academy of Sciences 88:2441-2445. Cerca con Google

33. Daheshia M, Feldman LT and Rouse BT (1998) Herpes simplex virus latency and the immune response. Current Opinion in Microbiology 1:430-435. Cerca con Google

34. De Giorgio R, Brun P, Zoppellaro C, Giron M, Felicani C, Barbara G, Stanghellini V, Bracceschi M, Pal G, Zaninotto G, Tonini M, Coriandolesi R, Gaion R and Castagliuolo I (2007) Evidence of small bowel neuro-muscular abnormalities in a rat model of Herpes Simplex Virus-1 (HSV1) infection of the Enteric Nervous System. Supplement to Gastroenterology 132:A136-A137. Cerca con Google

35. De Giorgio R, Guerrini S, Barbara G, Stanghellini V, De Ponti F, Corinaldesi R, Moses PL, Sharkey KA and Mawe GM (2004) Inflammatory neuropathies of the enteric nervous system. Gastroenterology 126:1872-1883. Cerca con Google

36. De Man JG, Seerden TA, De Winter BY, Van Marck EA, Herman AG and Pelckmans PA (2003) Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation. Br J Pharmacol 139:172-184. Cerca con Google

37. De Ponti F, Giaroni C, Cosentino M, Lecchini S and Frigo G (1996) Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications. Pharmacology & Therapeutics 69:59-78. Cerca con Google

38. Dixon A, Gubitz A, Sirinathsinghji D, Richardson P and Freeman T (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118:1461-1468. Cerca con Google

39. Duarte-Araujo M, Nascimento C, Alexandrina Timoteo M, Magalhaes-Cardoso T and Correia-de-Sa P (2004) Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A2A and extrajunctional inhibitory A1 receptors. Br J Pharmacol 141:925-934. Cerca con Google

40. Eddinger TJ, Schiebout JD and Swartz DR (2005) Smooth muscle adherens junctions associated proteins are stable at the cell periphery during relaxation and activation. Am J Physiol Cell Physiol 289:C1379-1387. Cerca con Google

41. Efstathiou S and Preston CM (2005) Towards an understanding of the molecular basis of herpes simplex virus latency. Virus Research 111:108-119. Cerca con Google

42. Elalamy I, Said FA, Singer M, Couetil JP and Hatmi M (2000) Inhibition by extracellular cAMP of phorbol 12-myristate 13-acetate-induced prostaglandin H synthase-2 expression in human pulmonary microvascular endothelial cells. Involvement of an ecto-protein kinase a activity. J Biol Chem 275:13662-13667. Cerca con Google

43. Eltzschig HK, Faigle M, Knapp S, Karhausen J, Ibla J, Rosenberger P, Odegard KC, Laussen PC, Thompson LF and Colgan SP (2006) Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 108:1602-1610. Cerca con Google

44. Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, Enjyoji K, Robson SC and Colgan SP (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198:783-796. Cerca con Google

45. Escriche M, Burgueno J, Ciruela F, Canela EI, Mallol J, Enrich C, Lluis C and Franco R (2003) Ligand-induced caveolae-mediated internalization of A1 adenosine receptors: morphological evidence of endosomal sorting and receptor recycling. Experimental Cell Research 285:72-90. Cerca con Google

46. Franco R, Casado V, Ciruela F, Saura C, Mallol J, Canela EI and Lluis C (1997) Cell surface adenosine deaminase: much more than an ectoenzyme. Progress in Neurobiology 52:283-294. Cerca con Google

47. Gao Z-G and Jacobson KA (2007) Emerging adenosine receptor agonists. Expert Opinion on Emerging Drugs 12:479-492. Cerca con Google

48. Geiger B, Tokuyasu K, Dutton A and Singer S (1980) Vinculin, an intracellular protein localized at specialized sites where microfilament bundles terminate at cell membranes. Proc Natl Acad Sci U S A 77:4127-4131. Cerca con Google

49. Gesser R and Koo S (1996) Oral inoculation with herpes simplex virus type 1 infects enteric neuron and mucosal nerve fibers within the gastrointestinal tract in mice. J Virol 70:4097-4102. Cerca con Google

50. Gesser RM and Koo SC (1997) Latent herpes simplex virus type 1 gene expression in ganglia innervating the human gastrointestinal tract. J Virol 71:4103-4106. Cerca con Google

51. Gessi S, Merighi S, Varani K, Leung E, Mac Lennan S and Borea PA (2008) The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacology & Therapeutics 117:123-140. Cerca con Google

52. Giron MC, Bin A, Brun P, Etteri S, Bolego C, Florio C and Gaion RM (2008) Cyclic AMP in rat ileum: evidence for the presence of an extracellular cyclic AMP-adenosine pathway. Gastroenterology doi:10.1053/j.gastro.2008.1001.1030. Cerca con Google

53. Gorin E and Brenner T (1976) Extracellular metabolism of cyclic AMP. Biochimica et Biophysica Acta (BBA) - General Subjects 451:20-28. Cerca con Google

54. Gottardi CJ, Arpin M, Fanning AS and Louvard D (1996) The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. PNAS 93:10779-10784. Cerca con Google

55. Guzman J, Yu J, Suntres Z, Bozarov A, Cooke H, Javed N, Auer H, Palatini J, Hassanain H, Cardounel A, Javed A, Grants I, Wunderlich J and Christofi F (2006) ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis. Inflamm Bowel Dis 12:766-789. Cerca con Google

56. Gwee KA (2005) Irritable bowel syndrome in developing countries - a disorder of civilization or colonization? Neurogastroenterology & Motility 17:317-324. Cerca con Google

57. Haskò G and Cronstein BN (2004) Adenosine: an endogenous regulator of innate immunity. Trends in Immunology 25:33-39. Cerca con Google

58. Haskó G and Pacher P (2008) A2A receptors in inflammation and injury: lessons learned from transgenic animals. J Leukoc Biol 83:1-9. Cerca con Google

59. Haskó G, Pacher P, Deitch EA and Vizi ES (2007) Shaping of monocyte and macrophage function by adenosine receptors. Pharmacology & Therapeutics 113:264-275. Cerca con Google

60. Herrera C, Casado V, Ciruela F, Schofield P, Mallol J, Lluis C and Franco R (2001) Adenosine A2b receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol Pharmacol 59:127-134. Cerca con Google

61. Hofer AM and Lefkimmiatis K (2007) Extracellular calcium and cAMP: second messengers as "third messengers"? Physiology 22:320-327. Cerca con Google

62. Hunsucker SA, Mitchell BS and Spychala J (2005) The 5'-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacology & Therapeutics 107:1-30. Cerca con Google

63. Jackson EK, Mi Z and Dubey RK (2007) The extracellular cAMP-adenosine pathway significantly contributes to the in vivo production of adenosine. J Pharmacol Exp Ther 320:117-123. Cerca con Google

64. Jackson EK, Zacharia LC, Zhang M, Gillespie DG, Zhu C and Dubey RK (2006) cAMP-adenosine pathway in the proximal tubule. J Pharmacol Exp Ther 317:1219-1229. Cerca con Google

65. Jacobson KA and Gao Z-G (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247-264. Cerca con Google

66. Kadowaki M, Nagakura Y, Tokita K, Hanaoka K and Tomoi M (2003) Adenosine A1 receptor blockade reverses experimental postoperative ileus in rat colon. European Journal of Pharmacology 458:197-200. Cerca con Google

67. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP and Haase VH (2004) Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114:1098-1106. Cerca con Google

68. Kas-Deelen AM, Bakker WW, Olinga P, Visser J, de Maar EF, van Son WJ, The TH and Harmsen MC (2001) Cytomegalovirus infection increases the expression and activity of ecto-ATPase (CD39) and ecto-5'nucleotidase (CD73) on endothelial cells. FEBS Letters 491:21-25. Cerca con Google

69. Kaya S, Cetin E, Aridogan B, Arikan S and Demirci M (2007) Adenosine deaminase activity in serum of patients with hepatitis - a useful tool in monitoring clinical status. J Microbiol Immunol Infect 40:288-292. Cerca con Google

70. Khan I, Blennerhassett MG, Kataeva GV and Collins SM (1995) Interleukin 1 beta induces the expression of interleukin 6 in rat intestinal smooth muscle cells. Gastroenterology 108:1720-1728. Cerca con Google

71. Khan WI and Collins S (2006) Gut motor function: immunological control in enteric infection and inflammation. Clinical & Experimental Immunology 143:389-397. Cerca con Google

72. Kolachala V, Asamoah V, Wang L, Obertone T, Ziegler T, Merlin D and Sitaraman S (2005) TNF-α upregulates adenosine 2b (A2b) receptor expression and signaling in intestinal epithelial cells: a basis for A2bR overexpression in colitis. Cellular and Molecular Life Sciences (CMLS) 62:2647-2657. Cerca con Google

73. Kolachala VL, Bajaj R, Chalasani M and Sitaraman SV (2007) Purinergic mechanisms in gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol doi:10.1152/ajpgi.00454.02007. Cerca con Google

74. Kramer MF, Cook WJ, Roth FP, Zhu J, Holman H, Knipe DM and Coen DM (2003) Latent herpes simplex virus infection of sensory neurons alters neuronal gene expression. J Virol 77:9533-9541. Cerca con Google

75. Lachmann R (2003) Herpes simplex virus latency. Expert Rev Mol Med 5:1-14. Cerca con Google

76. Lasley RD, Narayan P, Uittenbogaard A and Smart EJ (2000) Activated cardiac adenosine A1 receptors translocate out of caveolae. J Biol Chem 275:4417-4421. Cerca con Google

77. Latini S and Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. Journal of Neurochemistry 79:463-484. Cerca con Google

78. Leão-Ferreira LR, Paes-de-Carvalho R, de Mello FG and Moussatché N (2002) Inhibition of vaccinia virus replication by adenosine in BSC-40 cells: involvement of A2 receptor-mediated PKA activation. Archives of Virology 147:1407-1423. Cerca con Google

79. Lecci A, Santicioli P and Maggi CA (2002) Pharmacology of transmission to gastrointestinal muscle. Current Opinion in Pharmacology 2:630-641. Cerca con Google

80. Lee JJ, Talubmook C and Parsons ME (2001) Activation of presynaptic A1-receptors by endogenous adenosine inhibits acetylcholine release in the guinea-pig ileum. Journal of Autonomic Pharmacology 21:29-38. Cerca con Google

81. Lewis BM, Pexa A, Francis K, Verma V, McNicol AM, Scanlon M, Deussen A, Evans WH, Rees DA and Ham J (2006) Adenosine stimulates connexin 43 expression and gap junctional communication in pituitary folliculostellate cells. FASEB J 20:2585-2587. Cerca con Google

82. Linden J (2006) New insights into the regulation of inflammation by adenosine. J Clin Invest 116:1835-1837. Cerca con Google

83. Lomax AE, O'Reilly M, Neshat S and Vanner SJ (2007) Sympathetic vasoconstrictor regulation of mouse colonic submucosal arterioles is altered in experimental colitis. J Physiol 583:719-730. Cerca con Google

84. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin reagent. J Biol Chem 193:265-275. Cerca con Google

85. Mabley JG, Pacher P, Liaudet L, Soriano FG, Haskò G, Marton A, Szabo C and Salzman AL (2003) Inosine reduces inflammation and improves survival in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 284:G138-144. Cerca con Google

86. Milojevic T, Reiterer V, Stefan E, Korkhov VM, Dorostkar MM, Ducza E, Ogris E, Boehm S, Freissmuth M and Nanoff C (2006) The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2a receptor. Mol Pharmacol 69:1083-1094. Cerca con Google

87. Monteleone I, Vavassori P, Biancone L, Monteleone G and Pallone F (2002) Immunoregulation in the gut: success and failures in human disease. Gut 50:60-64. Cerca con Google

88. Morabito L, Montesinos MC, Schreibman DM, Balter L, Thompson LF, Resta R, Carlin G, Huie MA and Cronstein BN (1998) Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 101:295-300. Cerca con Google

89. Moriwaki Y, Takahashi S, Tsutsumi Z, Ka T, Hada T and Yamamoto T (2004) Immunohistochemical demonstration of adenosine deaminase (ADA 1) in human tissues. Acta Histochem Cytochem 37:173-182. Cerca con Google

90. Naramatsu M, Yamashita T and Kokubun S (1997) The signalling pathway which causes contraction via P2-purinoceptors in rat urinary bladder smooth muscle. Br J Pharmacol 122:558-562. Cerca con Google

91. Nicholls J and Hourani SMO (1997) Characterization of adenosine receptors on rat ileum, ileal longitudinal muscle and muscularis mucosae. European Journal of Pharmacology 338:143-150. Cerca con Google

92. Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, Marini M, Sugawara K, Kozaiwa K, Otaka M, Watanabe S and Cominelli F (2005) Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of Inflammatory Bowel Disease. Gastroenterology 129:26-33. Cerca con Google

93. Opazo Saez A, Zhang W, Wu Y, Turner CE, Tang DD and Gunst SJ (2004) Tension development during contractile stimulation of smooth muscle requires recruitment of paxillin and vinculin to the membrane. Am J Physiol Cell Physiol 286:C433-447. Cerca con Google

94. Pesi R, Camici M, Micheli V, Notarantonio L, Jacomelli G and Tozzi M (2008) Identification of the nucleotidase responsible for the AMP hydrolysing hyperactivity associated with neurological and developmental disorders. Neurochemical Research 33:59-65. Cerca con Google

95. Picher M, Burch LH, Hirsh AJ, Spychala J and Boucher RC (2003) Ecto 5'-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 278:13468-13479. Cerca con Google

96. Poturoglu S, Kaymakoglu S, Polat NG, Ibrisim D, Ahishali E, Akyuz F, Badur S, Demir K and Mungan ZA (2007) A new agent for Tumour Necrosis Factor-alpha inhibition: in vitro effects of dipyridamole in Crohn's disease. Gastroenterology 132:A-558. Cerca con Google

97. Quigley EMM (2005) Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases? Chinese Journal of Digestive Diseases 6:122-132. Cerca con Google

98. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492. Cerca con Google

99. Rijnierse A, Nijkamp FP and Kraneveld AD (2007) Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacology & Therapeutics 116:207-235. Cerca con Google

100. Rogachev B, Ziv NY, Mazar J, Nakav S, Chaimovitz C, Zlotnik M and Douvdevani A (2006) Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation. Kidney Int 70:675-681. Cerca con Google

101. Ross R and Kariya B (1980) Morphogenesis of vascular smooth muscle in atherosclerosis and cell structure. In: Bohr DF, Somlyo AP, Sparks HY, eds. Handbook of physiology. The cardiovascular system. Bethesda: American Physiological Society, 69. Cerca con Google

102. Sainz de la Maza M, Wells P and Foster CS (1989) Cyclic nucleotide modulation of herpes simplex virus latency and reactivation. Invest Ophthalmol Vis Sci 30:2154-2159. Cerca con Google

103. Sands WA and Palmer TM (2005) Inhibition of pro-inflammatory cytokine receptor signalling by cAMP in vascular endothelial cells. Biochem Soc Trans 33:1126-1128. Cerca con Google

104. Sato T, Obata T, Yamanaka Y and Arita M (1997) Stimulation of alpha 1-adrenoceptors and protein kinase C-mediated activation of ecto-5'-nucleotidase in rat hearts in vivo. J Physiol 503:119-127. Cerca con Google

105. Schwede F, Maronde E, Genieser H-G and Jastorff B (2000) Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacology & Therapeutics 87:199-226. Cerca con Google

106. Siegmund B, Rieder F, Albrich S, Wolf K, Bidlingmaier C, Firestein GS, Boyle D, Lehr H-A, Loher F, Hartmann G, Endres S and Eigler A (2001) Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J Pharmacol Exp Ther 296:99-105. Cerca con Google

107. Sitaraman SV, Wang L, Wong M, Bruewer M, Hobert M, Yun CH, Merlin D and Madara JL (2002) The adenosine A2b receptor is recruited to the plasma membrane and associates with E3KARP and ezrin upon agonist stimulation. J Biol Chem 277:33188-33195. Cerca con Google

108. Smith JS and Robinson NJ (2002) Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. The Journal of Infectious Diseases 186:S3-S28. Cerca con Google

109. Spear PG (2004) Herpes simplex virus: receptors and ligands for cell entry. Cellular Microbiology 6:401-410. Cerca con Google

110. Stehle JH, Rivkees SA, Lee JJ, Weaver DR, Deeds JD and Reppert SM (1992) Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endocrinol 6:384-393. Cerca con Google

111. Storr M, Thammer J, Dunkel R, Schusdziarra V and Allescher H-D (2002) Modulatory effect of adenosine receptors on the ascending and descending neural reflex responses of rat ileum. BMC Neuroscience 3:21. Cerca con Google

112. Strohmeier GR, Lencer WI, Patapoff TW, Thompson LF, Carlson SL, Moe SJ, Carnes DK, Mrsny RJ and Madara JL (1997) Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. J Clin Invest 99:2588-2601. Cerca con Google

113. Strohmeier GR, Reppert SM, Lencer WI and Madara JL (1995) The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J Biol Chem 270:2387-2394. Cerca con Google

114. Sun WC, Cao Y, Jin L, Wang LZ, Meng F and Zhu XZ (2005) Modulating effect of adenosine deaminase on function of adenosine A1 receptors. Acta Pharmacologica Sinica 26:160-165. Cerca con Google

115. Sundaram U, Hassanain H, Suntres Z, Yu JG, Cooke HJ, Guzman J and Christofi FL (2003) Rabbit chronic ileitis leads to up-regulation of adenosine A1/A3 gene products, oxidative stress, and immune modulation. Biochemical Pharmacology 65:1529-1538. Cerca con Google

116. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF and Colgan SP (2002) Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110:993-1002. Cerca con Google

117. Thorn JA and Jarvis SM (1996) Adenosine transporters. General Pharmacology: The Vascular System 27:613-620. Cerca con Google

118. Toews ML (2006) Adenosine receptors find a new partner and move out. Mol Pharmacol 69:1075-1078. Cerca con Google

119. Trofatter KFJ and Daniels CA (1980) Effect of prostaglandins and cyclic adenosine 3',5'-monophosphate modulators on herpes simplex virus growth and interferon response in human cells. Infect Immun 27:158-167. Cerca con Google

120. Van Assche G, Barbara G, Deng Y, Lovato P, Gauldie J and Collins S (1999) Neurotransmitters modulate cytokine-stimulated interleukin 6 secretion in rat intestinal smooth muscle cells. Gastroenterology 116:346-353. Cerca con Google

121. Vendetti S, Patrizio M, Riccomi A and De Magistris MT (2006) Human CD4+ T lymphocytes with increased intracellular cAMP levels exert regulatory functions by releasing extracellular cAMP. J Leukoc Biol 80:880-888. Cerca con Google

122. Walsh-Reitz MM, Huang EF, Musch MW, Chang EB, Martin TE, Kartha S and Toback FG (2005) AMP-18 protects barrier function of colonic epithelial cells: role of tight junction proteins. Am J Physiol Gastrointest Liver Physiol 289:G163-171. Cerca con Google

123. Wang L, Kolachala V, Walia B, Balasubramanian S, Hall RA, Merlin D and Sitaraman SV (2004) Agonist-induced polarized trafficking and surface expression of the adenosine 2b receptor in intestinal epithelial cells: role of SNARE proteins. Am J Physiol Gastrointest Liver Physiol 287:G1100-1107. Cerca con Google

124. Weiser MM (1973) Intestinal epithelial cell surface membrane glycoprotein synthesis. I.An indicator of cellular differentiation. J Biol Chem 248:2536-2541. Cerca con Google

125. Yaar R, Jones M, Chen JF and Ravid K (2005) Animal models for the study of adenosine receptor function. Journal of Cellular Physiology 202:9-20. Cerca con Google

126. Zacher LA and Carey GB (1999) Cyclic AMP metabolism by swine adipocyte microsomal and plasma membranes. Comp Biochem Physiol B Biochem Mol Biol 124:61-71. Cerca con Google

127. Zimmermann H (1992) 5'-Nucleotidase: molecular structure and functional aspects. Biochem J 285:345-365. Cerca con Google

128. Zimmermann H and Braun N (1996) Extracellular metabolism of nucleotides in the nervous system. J Auton Pharmacol 16:397-400. Cerca con Google

129. Zoppellaro C, Brun P, Giron MC, Bin A, Gaion RM and Castagliuolo I (2007) Herpes Simplex Virus-1 infection alters the carbachol- and KCl-induced contractions in rat small intestine. Book of Abstract Cagliari, June 6-9. Cerca con Google

Download statistics

Solo per lo Staff dell Archivio: Modifica questo record